AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
CEREBROSPINAL-FLUID INTERLEUKIN-6 IN AMYOTROPHIC-LATERAL-SCLEROSIS - IMMUNOLOGICAL PARAMETER AND COMPARISON WITH INFLAMMATORY AND NONINFLAMMATORY CENTRAL-NERVOUS-SYSTEM DISEASES
Authors: SEKIZAWA T OPENSHAW H OHBO K SUGAMURA K ITOYAMA Y NILAND JC
Citation: T. Sekizawa et al., CEREBROSPINAL-FLUID INTERLEUKIN-6 IN AMYOTROPHIC-LATERAL-SCLEROSIS - IMMUNOLOGICAL PARAMETER AND COMPARISON WITH INFLAMMATORY AND NONINFLAMMATORY CENTRAL-NERVOUS-SYSTEM DISEASES, Journal of the neurological sciences, 154(2), 1998, pp. 194-199
EVALUATION OF A QUANTITATIVE PLASMA PCR PLATE ASSAY FOR DETECTING CYTOMEGALOVIRUS-INFECTION IN MARROW TRANSPLANT RECIPIENTS
Authors: GALLEZHAWKINS GM TEGTMEIER BR TERVEER A NILAND JC FORMAN SJ ZAIA JA
Citation: Gm. Gallezhawkins et al., EVALUATION OF A QUANTITATIVE PLASMA PCR PLATE ASSAY FOR DETECTING CYTOMEGALOVIRUS-INFECTION IN MARROW TRANSPLANT RECIPIENTS, Journal of clinical microbiology, 35(3), 1997, pp. 788-790
LATE CYTOMEGALOVIRUS DISEASE IN MARROW TRANSPLANTATION IS PREDICTED BY VIRUS LOAD IN PLASMA
Authors: ZAIA JA GALLEZHAWKINS GM TEGTMEIER BR TERVEER A LI XL NILAND JC FORMAN SJ
Citation: Ja. Zaia et al., LATE CYTOMEGALOVIRUS DISEASE IN MARROW TRANSPLANTATION IS PREDICTED BY VIRUS LOAD IN PLASMA, The Journal of infectious diseases, 176(3), 1997, pp. 782-785
A PROSPECTIVE RANDOMIZED TRIAL COMPARING CYCLOSPORINE-A AND PREDNISONE (CSA PSE) VERSUS CYCLOSPORINE-A, METHOTREXATE AND PREDNISONE (CSA/MTX/PSE) FOR THE PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE - EFFECT ON CHRONIC GRAFT-VERSUS-HOST DISEASE AND LONG-TERM SURVIVAL/
Authors: ROSS M FORMAN SJ WONG RM SCHMIDT GM NILAND JC AMYLON MD DAGIS AC LONG GD NADEMANEE AP NEGRIN RS ODONNELL MR PARKER PM SMITH EP SYNDER DS STEIN AS BLUME KG CHAO NJ
Citation: M. Ross et al., A PROSPECTIVE RANDOMIZED TRIAL COMPARING CYCLOSPORINE-A AND PREDNISONE (CSA PSE) VERSUS CYCLOSPORINE-A, METHOTREXATE AND PREDNISONE (CSA/MTX/PSE) FOR THE PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE - EFFECT ON CHRONIC GRAFT-VERSUS-HOST DISEASE AND LONG-TERM SURVIVAL/, Blood, 90(10), 1997, pp. 2624-2624
MYELODYSPLASTIC SYNDROME OCCURRING AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR LYMPHOMA - MORPHOLOGIC FEATURES
Authors: WILSON CS TRAWEEK ST SLOVAK ML NILAND JC FORMAN SJ BRYNES RK
Citation: Cs. Wilson et al., MYELODYSPLASTIC SYNDROME OCCURRING AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR LYMPHOMA - MORPHOLOGIC FEATURES, American journal of clinical pathology, 108(4), 1997, pp. 369-377
MYELODYSPLASIA AND ACUTE MYELOID-LEUKEMIA OCCURRING AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR LYMPHOMA
Authors: TRAWEEK ST SLOVAK ML NADEMANEE AP BRYNES RK NILAND JC FORMAN SJ
Citation: St. Traweek et al., MYELODYSPLASIA AND ACUTE MYELOID-LEUKEMIA OCCURRING AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR LYMPHOMA, Leukemia & lymphoma, 20(5-6), 1996, pp. 365-372
POLYMYOSITIS AS A MANIFESTATION OF CHRONIC GRAFT-VERSUS-HOST DISEASE
Authors: PARKER P CHAO NJ BENEZRA J SLATKIN N OPENSHAW H NILAND JC LINKER CA GREFFE BS KASHYAP A MOLINA A NADEMANEE A ODONNELL MR PLANAS I SHEIBANI K SMITH EP SNYDER DS SPIELBERGER R STEIN AS STEPAN DE BLUME KG FORMAN SJ
Citation: P. Parker et al., POLYMYOSITIS AS A MANIFESTATION OF CHRONIC GRAFT-VERSUS-HOST DISEASE, Medicine, 75(5), 1996, pp. 279-285
MYELODYSPLASIC SYNDROME (MDS) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (AUTO-BMT) FOR LYMPHOMA - MORPHOLOGIC FEATURES
Authors: WILSON CS TRAWEEK ST SLOVAK ML NILAND JC BRYNES RK
Citation: Cs. Wilson et al., MYELODYSPLASIC SYNDROME (MDS) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (AUTO-BMT) FOR LYMPHOMA - MORPHOLOGIC FEATURES, Laboratory investigation, 74(1), 1996, pp. 735-735
A RANDOM TRIAL OF 12-WEEK VS 6-WEEK PREEMPTIVE GANCICLOVIR THERAPY INALLOGENEIC MARROW TRANSPLANTATION - INTERIM ANALYSIS
Authors: ZAIA JA CHAO NJ RIZK NW GALLEZHAWKINS GM DAGIS A TERVEER A NILAND JC BLUME KG FORMAN SJ
Citation: Ja. Zaia et al., A RANDOM TRIAL OF 12-WEEK VS 6-WEEK PREEMPTIVE GANCICLOVIR THERAPY INALLOGENEIC MARROW TRANSPLANTATION - INTERIM ANALYSIS, Blood, 88(10), 1996, pp. 1681-1681
LATE CMV DISEASE IN MARROW TRANSPLANTATION IS PREDICTED BY VIRUS LOADIN PLASMA
Authors: GALLEZHAWKINS GM LI X TEGTMEIER BR TERVEER A NILAND JC FORMAN SJ ZAIA JA
Citation: Gm. Gallezhawkins et al., LATE CMV DISEASE IN MARROW TRANSPLANTATION IS PREDICTED BY VIRUS LOADIN PLASMA, Blood, 88(10), 1996, pp. 1688-1688
INVOLVED FIELD RADIATION-THERAPY FOR HODGKINS-DISEASE AUTOLOGOUS BONE-MARROW TRANSPLANTATION REGIMENS
Authors: PEZNER RD NADEMANEE A NILAND JC VORA N FORMAN SJ
Citation: Rd. Pezner et al., INVOLVED FIELD RADIATION-THERAPY FOR HODGKINS-DISEASE AUTOLOGOUS BONE-MARROW TRANSPLANTATION REGIMENS, Radiotherapy and oncology, 34(1), 1995, pp. 23-29
THALIDOMIDE AS SALVAGE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE
Authors: PARKER PM CHAO N NADEMANEE A ODONNELL MR SCHMIDT GM SNYDER DS STEIN AS SMITH EP MOLINA A STEPAN DE KASHYAP A PLANAS I SPIELBERGER R SOMLO G MARGOLIN K ZWINGENBERGER K WILSMAN K NEGRIN RS LONG GD NILAND JC BLUME KG FORMAN SJ
Citation: Pm. Parker et al., THALIDOMIDE AS SALVAGE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE, Blood, 86(9), 1995, pp. 3604-3609
THE OUTCOME OF MATCHED UNRELATED DONOR BONE-MARROW TRANSPLANTATION INPATIENTS WITH HEMATOLOGIC MALIGNANCIES USING MOLECULAR TYPING FOR DONOR SELECTION AND GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS REGIMEN OF CYCLOSPORINE, METHOTREXATE, AND PREDNISONE
Authors: NADEMANEE A SCHMIDT GM PARKER P DAGIS AC STEIN A SNYDER DS ODONNELL M SMITH EP STEPAN DE MOLINA A WONG KK MARGOLIN K SOMLO G LITTRELL B WOO D SNIECINSKI I NILAND JC FORMAN SJ
Citation: A. Nademanee et al., THE OUTCOME OF MATCHED UNRELATED DONOR BONE-MARROW TRANSPLANTATION INPATIENTS WITH HEMATOLOGIC MALIGNANCIES USING MOLECULAR TYPING FOR DONOR SELECTION AND GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS REGIMEN OF CYCLOSPORINE, METHOTREXATE, AND PREDNISONE, Blood, 86(3), 1995, pp. 1228-1234
CHROMOSOMAL-ABNORMALITIES IN NON-HODGKINS-LYMPHOMA (NHL) - ASSOCIATIONS WITH HISTOLOGY, CLINICAL CHARACTERISTICS, AND TREATMENT OUTCOME IN 89 PATIENTS
Authors: SLOVAK ML NADEMANEE A NILAND JC WEISS LM FORMAN SJ
Citation: Ml. Slovak et al., CHROMOSOMAL-ABNORMALITIES IN NON-HODGKINS-LYMPHOMA (NHL) - ASSOCIATIONS WITH HISTOLOGY, CLINICAL CHARACTERISTICS, AND TREATMENT OUTCOME IN 89 PATIENTS, Blood, 86(10), 1995, pp. 2114-2114
INTENSIVE CHEMOTHERAPY OR BONE-MARROW TRANSPLANTATION FOR ADULT ALL IN FIRST COMPLETE REMISSION - A PHASE-III TRIAL
Authors: FORMAN SJ CHAO N NILAND JC LEVITT L CHAMPLIN R GAJEWSKI J LEE J SCHILLER G NANTEL S BARNETT M LEVINE A SAEZ R PHILLIPS G BHUME KG
Citation: Sj. Forman et al., INTENSIVE CHEMOTHERAPY OR BONE-MARROW TRANSPLANTATION FOR ADULT ALL IN FIRST COMPLETE REMISSION - A PHASE-III TRIAL, Blood, 86(10), 1995, pp. 2453-2453
A SURVEY OF BIOSTATISTICAL CONSULTING UNITS THROUGHOUT NORTH-AMERICA
Authors: NILAND JC ODOMMARYON TL LEE J TILLEY BC
Citation: Jc. Niland et al., A SURVEY OF BIOSTATISTICAL CONSULTING UNITS THROUGHOUT NORTH-AMERICA, The American statistician, 49(2), 1995, pp. 183-189
HIGH-DOSE THERAPY FOLLOWED BY AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA USING UNPRIMED AND GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS
Authors: NADEMANEE A SNIECINSKI I SCHMIDT GM DAGIS AC ODONNELL MR SNYDER DS PARKER PM STEIN AS SMITH EP MOLINA A STEPAN DE SOMLO G MARGOLIN KA WOO D NILAND JC FORMAN SJ
Citation: A. Nademanee et al., HIGH-DOSE THERAPY FOLLOWED BY AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA USING UNPRIMED AND GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS, Journal of clinical oncology, 12(10), 1994, pp. 2176-2186
FRACTIONATED TOTAL-BODY IRRADIATION AND HIGH-DOSE ETOPOSIDE AS A PREPARATORY REGIMEN FOR BONE-MARROW TRANSPLANTATION FOR 94 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE
Authors: SNYDER DS NEGRIN RS ODONNELL MR CHAO NJ AMYLON MD LONG GD NADEMANEE AP STEIN AS PARKER PM SMITH EP SOMLO G MARGOLIN K MOLINA A STEPAN DE LIPSETT JA HOPPE RT SLOVAK ML NILAND JC DAGIS AC WONG RM FORMAN SJ BLUME KG
Citation: Ds. Snyder et al., FRACTIONATED TOTAL-BODY IRRADIATION AND HIGH-DOSE ETOPOSIDE AS A PREPARATORY REGIMEN FOR BONE-MARROW TRANSPLANTATION FOR 94 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE, Blood, 84(5), 1994, pp. 1672-1679
CLONAL KARYOTYPIC HEMATOPOIETIC-CELL ABNORMALITIES OCCURRING AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA
Authors: TRAWEEK ST SLOVAK ML NADEMANEE AP BRYNES RK NILAND JC FORMAN SJ
Citation: St. Traweek et al., CLONAL KARYOTYPIC HEMATOPOIETIC-CELL ABNORMALITIES OCCURRING AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA, Blood, 84(3), 1994, pp. 957-963
USE OF PREEMPTIVE GANCICLOVIR BASED SOLELY ON ASYMPTOMATIC PULMONARY CYTOMEGALOVIRUS-INFECTION IN MARROW TRANSPLANT RECIPIENTS - LONG-TERM FOLLOW-UP
Authors: ZAIA JA SCHMIDT GM CHAO NJ RIZK N NADEMANEE AP NILAND JC HORAK DA LEE J GALLEZHAWKINS G KUSNIERZGLAZ CR ODONNELL MR PARKER PM SNYDER DS SMITH EP STEIN A MOLINA A STEPAN D BLUME KG FORMAN SJ
Citation: Ja. Zaia et al., USE OF PREEMPTIVE GANCICLOVIR BASED SOLELY ON ASYMPTOMATIC PULMONARY CYTOMEGALOVIRUS-INFECTION IN MARROW TRANSPLANT RECIPIENTS - LONG-TERM FOLLOW-UP, Blood, 84(10), 1994, pp. 10000249-10000249
NEUTROPENIA IS A COMPLICATION OF THALIDOMIDE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE
Authors: PARKER PM NADEMANEE A ODONNELL MR SNYDER DS STEIN A SMITH E MOLINA A STEPAN DE CHAO N NILAND JC BLUME KG FORMAN SJ
Citation: Pm. Parker et al., NEUTROPENIA IS A COMPLICATION OF THALIDOMIDE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE, Blood, 84(10), 1994, pp. 10000335-10000335
CYCLOSPORINE, METHOTREXATE, AND PREDNISONE COMPARED WITH CYCLOSPORINEAND PREDNISONE FOR PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE
Authors: CHAO NJ SCHMIDT GM NILAND JC AMYLON MD DAGIS AC LONG GD NADEMANEE AP NEGRIN RS ODONNELL MR PARKER PM SMITH EP SNYDER DS STEIN AS WONG RM BLUME KG FORMAN SJ
Citation: Nj. Chao et al., CYCLOSPORINE, METHOTREXATE, AND PREDNISONE COMPARED WITH CYCLOSPORINEAND PREDNISONE FOR PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE, The New England journal of medicine, 329(17), 1993, pp. 1225-1230
FRACTIONATED TOTAL-BODY IRRADIATION AND HIGH-DOSE ETOPOSIDE AS A PREPARATORY REGIMEN FOR BONE-MARROW TRANSPLANTATION FOR 99 PATIENTS WITH ACUTE-LEUKEMIA IN 1ST COMPLETE REMISSION
Authors: SNYDER DS CHAO NJ AMYLON MD TAGUCHI J LONG GD NEGRIN RS NADEMANEE AP ODONNELL MR SCHMIDT GM STEIN AS PARKER PM SMITH EP STEPAN DE MOLINA A LIPSETT JA HOPPE RT NILAND JC DAGIS AC WONG RM FORMAN SJ BLUME KG
Citation: Ds. Snyder et al., FRACTIONATED TOTAL-BODY IRRADIATION AND HIGH-DOSE ETOPOSIDE AS A PREPARATORY REGIMEN FOR BONE-MARROW TRANSPLANTATION FOR 99 PATIENTS WITH ACUTE-LEUKEMIA IN 1ST COMPLETE REMISSION, Blood, 82(9), 1993, pp. 2920-2928
THE OUTCOME OF MATCHED UNRELATED DONOR (MUD) BONE-MARROW TRANSPLANTATION IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES UTILIZING MOLECULAR TYPING FOR DONOR SELECTION
Authors: NADEMANEE A SCHMIDT GM LITTRELL B NILAND JC PARKER PM ODONNELL MR SNYDER DS STEIN A SMITH E MOLINA A WONG KK MARGOLIN K FORMAN SJ
Citation: A. Nademanee et al., THE OUTCOME OF MATCHED UNRELATED DONOR (MUD) BONE-MARROW TRANSPLANTATION IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES UTILIZING MOLECULAR TYPING FOR DONOR SELECTION, Blood, 82(10), 1993, pp. 10000079-10000079
FRACTIONATED TOTAL-BODY IRRADIATION (FTBI), HIGH-DOSE ETOPOSIDE (VP-16) AND CYCLOPHOSPHAMIDE (CY) FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) - THE RESULTS IN 110 PATIENTS WITH NON-HODGKINS-LYMPHOMA (NHL)
Authors: NADEMANEE A SCHMIDT GM ODONNELL MR SNYDER DS PARKER PM STEIN A SMITH E MOLINA A WONG KK STEPAN DE MARGOLIN KA SOMLO G RASCHKO J SNIECINSKI I LIPSETT JA DAGIS A NILAND JC FORMAN SJ
Citation: A. Nademanee et al., FRACTIONATED TOTAL-BODY IRRADIATION (FTBI), HIGH-DOSE ETOPOSIDE (VP-16) AND CYCLOPHOSPHAMIDE (CY) FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) - THE RESULTS IN 110 PATIENTS WITH NON-HODGKINS-LYMPHOMA (NHL), Blood, 82(10), 1993, pp. 10000143-10000143
Risultati: 1-25 | 26-27